Author Topic: STDY - SteadyMed Ltd  (Read 5091 times)

Foreign Tuffett

  • Hero Member
  • *****
  • Posts: 899
Re: STDY - SteadyMed Ltd
« Reply #10 on: August 23, 2018, 10:21:45 AM »
Still time to jump on this train before the transaction closes next month. If nothing else, this is a high max upside ($2.63 per share CVR) vs low max downside ($0.24 per share at the current $4.70 STDY price) type of opportunity.

I won't pretend to be an expert on the treatment of pulmonary arterial hypertension (PAH), but with most of United Therapeutics' PAH drugs going off patent this year or next, it should be quite incentivized to transition patients to Trevyent. Trevyent purports to be a superior PAH medication delivery system.

Time arbitrage, illiquidity arbitrage, NPVs, probability of receiving the CVR -- these are the types of issues at play here.


hillfronter83

  • Full Member
  • ***
  • Posts: 220
Re: STDY - SteadyMed Ltd
« Reply #11 on: September 10, 2018, 06:31:26 AM »
Deal closed 8/31/2018. Did anyone receive cash in their account? I haven't in IB. Wondering why it takes so long.

Broeb22

  • Full Member
  • ***
  • Posts: 186
Re: STDY - SteadyMed Ltd
« Reply #12 on: September 10, 2018, 06:50:31 AM »
I have not either. Also have IB.

rijk

  • Lifetime Member
  • Sr. Member
  • *****
  • Posts: 320
Re: STDY - SteadyMed Ltd
« Reply #13 on: September 10, 2018, 08:30:03 AM »
israeli mergers usually take (a lot) longer, foreign holders need to complete an additional tax certificate to avoid local withholding tax, per ib the related paperwork will appear in the corporate actions tool..... hopefully in the near future.....


writser

  • Hero Member
  • *****
  • Posts: 1900
Re: STDY - SteadyMed Ltd
« Reply #14 on: October 11, 2018, 09:25:29 AM »
I completed the paperwork for STDY about two weeks ago. Bit of a hassle but nothing too complicated. Received my (tax-free) merger consideration today. Cost basis for the CVR: ~$0.06 (flipped a few shares opportunistically). Valuation at time of delisting: $0.26. We'll see how things turn out. Price paid wasn't too bad but there was a bit of an opportunity cost in holding the shares for ~5 months.
When you are dead, you do not know you are dead. It's only painful and difficult for others. The same applies when you are stupid.

writser

  • Hero Member
  • *****
  • Posts: 1900
Re: STDY - SteadyMed Ltd
« Reply #15 on: February 28, 2019, 06:09:01 AM »
From the United Therapeutics 10K:
Quote
We ascribed no value to the contingent value rights based on a probability-weighted discounted cash flow model, utilizing probability adjusted expectations for achieving the Milestone. In making this determination we considered expectations regarding the timing and probability of FDA approval of Trevyent, the potential patient population, and estimates of product penetration and uptake by August 30, 2023. As of December 31, 2018, there have been no material changes in assumptions used as of the closing date and, therefore, no changes to the value of the contingent consideration.
When you are dead, you do not know you are dead. It's only painful and difficult for others. The same applies when you are stupid.